Literature DB >> 18025425

Autoimmune diseases after adolescent or adult immunization: what should we expect?

Claire-Anne Siegrist1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18025425      PMCID： PMC2072979          DOI： 10.1503/cmaj.071134

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Causality assessment of adverse events following immunization.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2001-03-23

2.  No link established between deaths in elderly patients in Israel and influenza vaccination.

Authors: 
Journal:  Euro Surveill       Date:  2006-10-26

Review 3.  Mass vaccination against hepatitis B: the French example.

Authors:  F Denis; D Levy-Bruhl
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 4.  Vaccines for preventing influenza in the elderly.

Authors:  D Rivetti; T Jefferson; R Thomas; M Rudin; A Rivetti; C Di Pietrantonj; V Demicheli
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions.

Authors:  Claire-Anne Siegrist; Edwin M Lewis; Juhani Eskola; Stephen J W Evans; Steven B Black
Journal:  Pediatr Infect Dis J       Date:  2007-11       Impact factor: 2.129

Review 6.  Vaccination and autoimmune disease: what is the evidence?

Authors:  David C Wraith; Michel Goldman; Paul-Henri Lambert
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321
  6 in total
  8 in total

Review 1.  Safety of Human Papillomavirus Vaccines: An Updated Review.

Authors:  Anastasia Phillips; Cyra Patel; Alexis Pillsbury; Julia Brotherton; Kristine Macartney
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

2.  Association between Human Papilloma Virus (HPV) vaccination and risk of Multiple Sclerosis: A systematic review.

Authors:  Angela Meggiolaro; Giuseppe Migliara; Giuseppe La Torre
Journal:  Hum Vaccin Immunother       Date:  2018-01-30       Impact factor: 3.452

Review 3.  Safety of human papillomavirus vaccines: a review.

Authors:  Kristine K Macartney; Clayton Chiu; Melina Georgousakis; Julia M L Brotherton
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

4.  Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States.

Authors:  Julianne Gee; Cindy Weinbaum; Lakshmi Sukumaran; Lauri E Markowitz
Journal:  Hum Vaccin Immunother       Date:  2016-03-30       Impact factor: 3.452

5.  Human papillomavirus vaccination and all-cause morbidity in adolescent girls: a cohort study of absence from school due to illness.

Authors:  Anders Hviid; Nicklas M Thorsen; Louise N Thomsen; Frederik T Møller; Andreas Wiwe; Morten Frisch; Palle Valentiner-Branth; Dorte Rytter; Kåre Mølbak
Journal:  Int J Epidemiol       Date:  2021-05-17       Impact factor: 7.196

6.  The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.

Authors:  Lucy Deng; Catherine Glover; Michael Dymock; Alexis Pillsbury; Julie A Marsh; Helen E Quinn; Alan Leeb; Patrick Cashman; Thomas L Snelling; Nicholas Wood; Kristine Macartney
Journal:  Med J Aust       Date:  2022-07-04       Impact factor: 12.776

7.  Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study.

Authors:  Lisen Arnheim-Dahlström; Björn Pasternak; Henrik Svanström; Pär Sparén; Anders Hviid
Journal:  BMJ       Date:  2013-10-09

8.  The public perception of the value of vaccines - the case of Switzerland.

Authors:  Claire-Anne Siegrist; Marta A Balinska Peroutkova
Journal:  Z Gesundh Wiss       Date:  2008-06-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.